-

AIS Healthcare Prioritizes Patient Safety and Well-being on World Patient Safety Day

DALLAS--(BUSINESS WIRE)--AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is proud to recognize September 17th as World Patient Safety Day. Throughout its TDD and infusion care divisions, AIS Healthcare is committed to advancing quality and improving the lives of patients with a focus on safety and well-being.

Established in 2019 by the World Health Organization (WHO), World Patient Safety Day brings together patients, families, caregivers, nurses, and healthcare leaders to show their commitment to patient safety. AIS Healthcare reaffirms its pledge to continue exceeding industry standards to produce medications of the highest quality and sterility for individuals living with complex medical conditions. For in-home immunoglobulin therapy infusion and intrathecal pump medication delivery and maintenance, AIS Healthcare’s highly skilled nursing and pharmacy teams provide specialized care that leads to better patient outcomes.

World Patient Safety Day calls attention to the supreme importance of patient safety. “We believe that true progress in healthcare begins with patient safety as its foundation,” said Simon Castellanos, Chief Executive Officer of AIS Healthcare. “Our commitment to enhancing patient well-being through innovative solutions is unwavering. At AIS Healthcare, we strive to raise the bar across our industry to ensure patients have absolute trust in the safety and quality of their medications and services.”

Across its TDD division, AIS Healthcare ships more than 140,000 patient-specific prescriptions annually to all 50 states for patients managing chronic pain and complex medical conditions. Throughout its operations, AIS Healthcare goes beyond industry and state-level standards to produce medications of the highest safety and quality.

AIS Healthcare carries dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC), distinguishing itself as an industry leader in targeted drug delivery and infusion care. In observance of World Patient Safety Day, AIS Healthcare remains dedicated to delivering transformative services across the care continuum, consistently prioritizing patient safety and well-being.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com

Contacts

Simon Castellanos
877.443.4006

AIS Healthcare


Release Versions

Contacts

Simon Castellanos
877.443.4006

More News From AIS Healthcare

Advanced Infusion Care (AIC) now offers GC Biopharma’s ALYGLO™ [Immune Globulin Intravenous (Human-stwk) 10% liquid]

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, now offers ALYGLO™, manufactured by GC Biopharma, for the treatment of patients with primary humoral immunodeficiency (PI) in adults. This includes, but is not limited to, the humoral immune defect in congenital agammaglobulinemia, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiency (SCID). The nationally accredited home infusion teams at AIC collaborate c...

AIS Healthcare Supports Physicians and Patients Impacted by Hurricanes Helene and Milton

DALLAS--(BUSINESS WIRE)--In response to recent hurricanes that devastated many communities across the Southeastern United States, AIS Healthcare, a leading provider of targeted drug delivery (TDD) and infusion care solutions, is providing additional support to physicians and patients to ensure continuity of care and access to life-saving medication. The destruction of critical infrastructure and extended power outages have created acute challenges for patients who rely on timely delivery and su...

Advanced Infusion Care (AIC) Announces New Hire to Trade & Procurement Team

DALLAS--(BUSINESS WIRE)--AIC, a division of AIS Healthcare, today announced the hiring of Stan Singley as Vice President of Trade and Procurement. In this role, Stan will help drive AIC’s growth and expansion strategy in partnering with pharmaceutical manufacturers to gain limited distribution and sole source access for specialty drugs. “We are thrilled to welcome a highly respected industry veteran with more than 20+ years of experience in immunology and rare diseases,” said Jud Hall, Presiden...
Back to Newsroom